Pfizer has abandoned development of a hemophilia A gene therapy it licensed from Sangamo Therapeutics, a move that could imperil Sangamo’s future. It’s a sudden
In this Issue We explore psychedelics-related lobbying activity at the federal level in Q3’24, which saw a significant increase in such efforts Psychoplastogens a ‘primary
Table of Contents The end of 2024 marks two years in the books for the Oregon Psilocybin Services (OPS) program. It has been a long
Aletha Maybank, who became the American Medical Association’s first chief equity officer five and half years ago, is leaving the organization. Maybank, a widely respected
It’s easy to forget that we live in an age of medical wonders. Cancer tumors can be slowed or shrunk in ways previous generations couldn’t
Work by device manufacturers to improve the performance of pulse oximeters on people with darker skin has progressed little since the Food and Drug Administration
NuAire joins Kewaunee Scientific Corporation, enhancing laboratory solutions with a comprehensive portfolio of incubators, fume hoods, and biosafety cabinets.
The hormone estrogen regulates binge drinking in females, causing them to “pregame” – consume large quantities of alcohol in the first 30 minutes after it’s
Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new
Anemia significantly impacts global public health, with over 571 million women at risk of adverse health outcomes due to iron deficiency and other causes.